A crystalline compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating crystalline compound (1) are provided.
申请公布号
US8569488(B2)
申请公布日期
2013.10.29
申请号
US201113336512
申请日期
2011.12.23
申请人
DOWDY ERIC D.;KENT KENNETH M.;TOM NORMA J.;ZIA VAHID;GILEAD SCIENCES, INC.;K.U. LEUVEN RESEARCH & DEVELOPMENT
发明人
DOWDY ERIC D.;KENT KENNETH M.;TOM NORMA J.;ZIA VAHID
